Argyrophilic cells in breast ducts and ductules have been described by several workers in normal and abnormal breasts.'`4 Carcinoid tumours of the breast were subsequently reported on the basis of argyrophilia and dense core granules ultrastructurally. 5 More recently, neurone specific enolase positivity has contributed to the diagnosis. Some workers have taken a sceptical view of the endocrine nature of such cells, stating that Grimelius staining and dense core granules are not specific for endocrine cells.6 ' Azzopardi et al8 concluded that argyrophil carcinomas of the breast should be regarded as a distinctive group of tumours. In a recent study9 of endocrine tumours they found that a high proportion of in situ ductal carcinomas show an organoid pattern, with distinctive structural and cytological features, Accepted for publication 17 June 1986 neurone specific enolase positivity, and ultrastructural dense core granules. They applied the term endocrine variant of ductal carcinoma in situ to these tumours.
Case histories CASE 1
A 73 year old woman presented in April 1985 with a tender lump in the left breast, which she had noticed two weeks previously. Six years ago she had felt a lump in the upper quadrant of the same breast that had settled down before she was examined by the surgeon. A xerogram performed at the same time noted duct ectasia and collagenosis without any other abnormality. Her medication comprised digoxin (250 mg at night). She smoked 10 cigarettes daily and did not drink alcohol. dense core granules of a mean diameter of 360 nm. The number per cell varied from a few scattered granules to numerous granules filling the cytoplasm (fig 3) . Abundant rough endoplasmic reticulum was present, and there was a prominent Golgi body in many of the cells. Some of the cells, in addition to dense core granules, also contained mucin vacuoles, although these were not a prominent feature.
The organoid pattern, strong argyrophilia seen with the Grimelius stain, and the ultrastructural dense core granules enabled us to diagnose endocrine variant of ductal carcinoma in situ. CASE 2 A 72 year old woman presented with bloody painful discharge from the right nipple, which she had had for three weeks. She had systemic hypertension, which was controlled with timolol (1Omg twice daily) and bendrofluazide (2 5 mg daily).
Physical examination showed a firm tender lump measuring about 6 cm in diameter in the lower outer quadrant of the right breast, with skin tethering and nipple retraction. The left breast was grossly normal and general physical examination was unremarkable. Biochemical and haematological indices were normal. Right simple mastectomy with axillary clearance was performed. Postoperatively there was prolonged serous discharge from the surgical wound that eventually healed fully. The patient remained alive and well without evidence of recurrent or metastatic disease three months later.
The resected specimen consisted of a breast measuring 22 x 17 x 7-5cm with attached axillary fat.
Deep within the tissue was a nodular circumscribed grey tumour measuring 4 x 3 3 x 3 cm, which had not spread to skin, nipple, or deeper tissue. The surrounding breast tissue contained dilated ducts.
Histologically the tumour was similar to that described in case 1 (fig4), with the exception that many of the tumour units showed polypoid projections into cystic spaces, some covered with ductal epithelium. There were also areas of conventional ductal carcinoma in situ with a cribriform pattern. The histological changes not only were present in the main tumour mass but also in ducts of surrounding breast, including the large ducts beneath the nipple. Staining by the Grimelius method showed strong argyrophilia in most of the tumour cells ( fig 5) . No staining was seen in the areas of conventional ductal carcinoma in situ. Ultrastructurally the cells contained moderate numbers of dense core granuls ( fig 6) . Discussion Volger' in 1947 found argyrophilic cells in breast ducts of one of 18 specimens studied. Other workers have failed to find argyrophil cells in normal breast or benign breast lesions.2 3 A recent report,4 however, has described argyrophilic and chromogranin reactive endocrine cells in breast ducts and ductules in three of 27 cases of normal breast tissue.
In 1977 Cubilla and Woodruff' reported 10 primary tumours of the breast, which they termed carcinoids. The tumours had an organoid appearance, exhibited argyrophilia, and, in three cases examined ultrastructurally, contained dense core granules.
Several case reports followed,'0 " including an argentaffin carcinoid reported by Devitt,'2 although its validity is doubtful Taxy et al6 reported a further case, but in addition examined 21 "ordinary" carcinomas of the breast and found focal argyrophilia in 11 (an incidence of 52%). They took a sceptical view of the endocrine nature of such cells, stating that Grimelius staining was not specific for endocrine cells and that dense core granules described in these cells may have been lysosomes or mucin vacuoles. They concluded that, "some breast cancers may focally exhibit a carcinoid-like differentiation." Anderson et al7 doubted that all three features-that is, dense core granules, neurone specific enolase, and Grimelius positivity were specific for endocrine cells in the breast.
The high percentage of argyrophilia in conventional breast carcinomas found by Taxy et al has not been found by other workers. Azzopardi et al8 found argyrophilia in 4-5% of 67 invasive breast carcinomas. Partanen and Syrjanen2 reported a figure of 3-3% for 90 adenocarcinomas and Fetisof etal3 reported an incidence of 4-8% in 92 carcinomas.
Azzopardi et at8 described 14 so called "carcinoid" tumours of the breast, which had been tentatively selected on their histological and cytological appearance and subsequently confirmed by Grimelius staining. Four of these 14 tumours (28-5%) were the argyrophil type of ductal carcinoma in situ, five (35 7%) invasive ductal carcinoma, one (7-1%) invasive lobular carcinoma and the others were complex types. They concluded that "argyrophil carcinomas" of the breast should be regarded as forming a reasonably distinctive and relatively small group of tumours. As the so called "carcinoid tumour" had been difficult to define in the breast in a more recent study9 the authors studied 30 consecutive cases of in situ carcinoma of the breast in an attempt to clarify the complex problems entailed. Seven of the 30 cases (23 3%) were considered to be the entity of endocrine variant of ductal carcinoma in situ identified by organoid pattern, structural and cytological characteristics, argyrophilia, and ultrastructurally, by dense core granules. They regarded it as a variant of the solid type of ductal carcinoma in situ, arising by divergent differentiation from ductal epithelium. Our 
